NCT05435339 2025-04-22A Study to Evaluate Safety, Tolerability, and Preliminary Effect of the GEN1053 Antibody on Malignant Solid Tumors as MonotherapyGenmabPhase 1/2 Terminated31 enrolled 29 charts